Gil Gonen Yaacovi, PhD

Associate Director, Clinical and Regulatory Affairs
ASC Therapeutics

Gil Gonen-Yaacovi, PhD, is Associate Director, Clinical and Regulatory Affairs at ASC Therapeutics. Dr. Gonen-Yaacovi has extensive experience in managing clinical trials and leading different regulatory submissions to multiple authorities. ASC Therapeutics is based in California, US, and is focused on gene therapy, cell therapy, and gene editing in multiple indications

Presentation(s):

• PB0662 - Clinical Study of Adenovirus-Associated Viral Vector-Mediated Gene Therapy of Human Factor VIII in Severe and Moderately Severe Hemophilia A

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PO0017 - Essential Biomarkers for a Clinical Study of a Novel Allogeneic Cell Therapy for Acute Graft-versus-Host Disease

  Wednesday, July 13, 2022
  1:00 PM – 2:00 PM